ARCHIVES

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

This article is from The Cancer Letter archive.

Vol. 22 No. 17 | April 26, 1996

Download PDF Visit The Full Archive

Related Articles

CDC Contribution To National Dialogue Raises Questions About Ties With ACS.

September 22, 2000

In Brief: Wilson Names Director, MCW cancer Center; UAB Cancer Center Makes Three Appointments

February 9, 1996

Edward Benz Named President Of Dana-Farber Cancer Institute.

July 28, 2000

Screening Guidelines: When Scientists Can’t Agree, What’s The Press To Do?

May 15, 1998

NCAB to Review Coding of Projects Addressing Minorites and Undeserved

February 19, 1999

NCI Audit Finds “Low Quality” Research At Calif. Foundation

June 17, 1994